Bristol-Myers Squibb Co delivered a strong second-quarter performance on Thursday, posting adjusted earnings of $2.04 per share against market estimates of $1.59 per share. The pharmaceutical giant also reported sales of $12.973 billion, well above the anticipated $11.745 billion. Following these results, the company raised its financial guidance for FY26, signaling confidence in its ongoing operational trajectory and product pipeline.

The positive earnings report contributed to a broader rally in U.S. equities midway through trading. The Dow Jones Industrial Average gained more than 200 points, rising 0.40% to close at 51,801.63. The NASDAQ Composite surged 2.08% to 24,952.56, while the S&P 500 index climbed 0.89% to reach 7,381.26. Information technology shares led the market advance, jumping by 4.4%, whereas communication services stocks declined by 3.2%.

Market Movers

Several equities experienced significant volatility driven by corporate announcements and regulatory developments. Columbus McKinnon Corp shares skyrocketed 40% to $20.44 after reporting upbeat quarterly results. Similarly, Xerox Holdings Corp gained 39% to $3.67 following better-than-expected quarterly financials. Marketaxess Holdings Inc surged 30% to $163.14 after Intercontinental Exchange announced its acquisition of the firm.

Conversely, Capricor Therapeutics Inc saw its shares plummet 54% to $3.00 after the FDA Advisory Committee voted against Deramiocel, an investigational cell therapy for Duchenne muscular dystrophy. Alnylam Pharmaceuticals, Inc. fell 27% to $209.70 due to mixed second-quarter results and a cut in FY26 sales guidance below estimates. Coastal Financial Corp dropped 41% to $41.97 after releasing its second-quarter earnings.

Commodities and Global Markets

In commodity trading, gold prices rose 3% to $4,156.90, while silver increased 0.5% to $58.390 and copper gained 2.6% to $6.4725. Oil prices slipped slightly, trading down 0.3% to $84.18. European markets closed higher, with the STOXX 600 rising 0.9%, Spain’s IBEX 35 gaining 1.5%, and France’s CAC 40 surging 1%. Asia-Pacific markets were mostly positive, with Japan’s Nikkei 225 up 0.71% and India’s BSE Sensex gaining 0.35%, though China’s Shanghai Composite fell 0.62%.

Economic Indicators

U.S. economic data showed mixed signals for June. Personal income increased 0.2% month-over-month, missing the estimated 0.3% rise but easing from May’s 0.7% gain. Personal spending rose 0.3%, slowing from a revised 0.9% increase in May. The PCE price index fell 0.1% month-over-month, following a 0.5% rise in May. Initial jobless claims rose by 9,000 to 197,000 for the week ending July 25, better than the expected 200,000. The U.S. economy grew at an annualized rate of 1.5% in the second quarter, down from 2.1% in the first quarter and below market estimates of 2.1%.

What the Numbers Show

Bristol-Myers Squibb’s ability to exceed both earnings and revenue expectations suggests strong underlying demand for its therapeutic portfolio. The significant beat in EPS ($2.04 vs $1.59) indicates effective cost management or higher-margin product mix, while the revenue upside ($12.973 billion vs $11.745 billion) reflects robust sales execution. This dual outperformance likely underpins the company’s decision to raise FY26 guidance, providing investors with a clearer path to future growth despite broader economic uncertainties reflected in the slowing GDP growth.

General Dynamics Corp reported second-quarter earnings that surpassed market expectations, posting earnings per share of $4.24 against analyst estimates of $3.96. The defense contractor also delivered stronger-than-anticipated top-line growth, with sales reaching $14.094 billion compared to the projected $13.535 billion. These results highlight robust demand in the sector despite broader market volatility.

The company’s performance stands out amid a mixed trading session for U.S. equities. The Dow Jones Industrial Average fell 1.58% to 51,915.42, while the NASDAQ Composite declined 1.19% to 24,580.72. The S&P 500 also retreated, dropping 0.89% to 7,362.68. Energy shares provided a bright spot, jumping 2.6%, whereas industrials stocks fell 1.9% in prior trading sessions.

Market Movers

Several equities saw significant price movements following corporate announcements. Verra Mobility Corp shares surged 30% to $5.42 after reaching a framework agreement with Avis Budget Group. Huron Consulting Group Inc gained 27% to $153.55 on upbeat second-quarter earnings. Manhattan Associates Inc rose 25% to $210.22 after reporting better-than-expected results and raising its FY26 guidance.

Conversely, Bandwidth Inc dropped 27% to $38.15 after cutting its FY26 adjusted EPS guidance below estimates. Processa Pharmaceuticals Inc fell 35% to $1.98 following a $200 million private placement and the acquisition of Vidya Therapeutics BTK Inhibitor VT-7208. Parsons Corp declined 41% to $36.51 after reporting worse-than-expected second-quarter sales and lowering its FY26 sales guidance.

Commodities and Global Markets

In commodity trading, crude oil prices rose 7.1% to $84.89, driven by a larger-than-expected inventory drawdown. U.S. crude inventories dipped by 7.167 million barrels in the week ended July 24, compared to market estimates of a 1.3 million-barrel draw. Precious metals faced headwinds, with gold falling 0.8% to $4,006.60, silver down 0.7% to $57.105, and copper declining 0.8% to $6.3070.

Global equity markets showed mixed performance. In Europe, the STOXX 600 fell 0.1%, while the FTSE 100 rose 0.4%. Asian markets were also varied, with Japan’s Nikkei 225 dipping 1.49% and Hong Kong’s Hang Seng index surging 1.96%. India’s BSE Sensex gained 1.2%.

Economic Indicators

U.S. economic data indicated cooling housing demand. Mortgage application volumes declined by 6.4% from the previous week in the week ending July 24. This decline suggests potential softening in the housing market amidst ongoing economic uncertainties.